These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18836339)

  • 1. Conclusion and future directions.
    Samlowski WE; Vogelzang NJ
    Cancer J; 2008; 14(5):330-2. PubMed ID: 18836339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatments for metastatic renal cell carcinoma.
    van Spronsen DJ; Mulders PF; De Mulder PH
    Crit Rev Oncol Hematol; 2005 Sep; 55(3):177-91. PubMed ID: 15979888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.
    Choueiri TK; Bukowski RM; Rini BI
    Semin Oncol; 2006 Oct; 33(5):596-606. PubMed ID: 17045089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel investigative approaches for advanced renal cell carcinoma.
    Berg WJ; Divgi CR; Nanus DM; Motzer RJ
    Semin Oncol; 2000 Apr; 27(2):234-9. PubMed ID: 10768602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of metastatic renal cell carcinoma.
    McDermott DF; Atkins MB
    Cancer J; 2008; 14(5):320-4. PubMed ID: 18836337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents for the treatment of renal cell carcinoma.
    Tian GG; Dawson NA
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):546-54. PubMed ID: 12113087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
    Halbert RJ; Figlin RA; Atkins MB; Bernal M; Hutson TE; Uzzo RG; Bukowski RM; Khan KD; Wood CG; Dubois RW
    Cancer; 2006 Nov; 107(10):2375-83. PubMed ID: 17048248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Judgment of Paris: treatment dilemmas in advanced renal cell carcinoma.
    Hwang C; Heath EI
    J Clin Oncol; 2014 Mar; 32(8):729-34. PubMed ID: 24516012
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel treatment strategies in clear-cell metastatic renal cell carcinoma.
    van Spronsen DJ; de Weijer KJ; Mulders PF; De Mulder PH
    Anticancer Drugs; 2005 Aug; 16(7):709-17. PubMed ID: 16027518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutics for metastatic renal cell carcinoma.
    Hutson TE; Figlin RA
    Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib: tolerance in patients on chronic hemodialysis: a single-center experience.
    Rey PM; Villavicencio H
    Oncology; 2008; 74(3-4):245-6. PubMed ID: 18716419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment approaches in renal cell carcinoma.
    Facchini G; Perri F; Caraglia M; Pisano C; Striano S; Marra L; Fiore F; Aprea P; Pignata S; Iaffaioli RV
    Anticancer Drugs; 2009 Nov; 20(10):893-900. PubMed ID: 19752718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastatic kidney cancer: new therapeutic approaches].
    Negrier S; Mejean A; Oudard S; Escudier B
    Prog Urol; 2002 Sep; 12(4):703-8. PubMed ID: 12463140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the guest editors: the dramatic advances in the treatment of metastatic renal cancer that have occurred over the last 3 years, with an eye toward the potential future directions of the field.
    Samlowski WE; Vogelzang NJ
    Cancer J; 2008; 14(5):286-7. PubMed ID: 18836332
    [No Abstract]   [Full Text] [Related]  

  • 19. Current management and future perspectives of metastatic renal cell carcinoma.
    Lee-Ying R; Lester R; Heng D
    Int J Urol; 2014 Sep; 21(9):847-55. PubMed ID: 24862210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
    Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.